Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MILES TAPS JOHN HOWELL TO HEAD U.S. CONSUMER HEALTHCARE

Executive Summary

MILES TAPS JOHN HOWELL TO HEAD U.S. CONSUMER HEALTHCARE division, the Bayer subsidiary announced in a May 4 press release. A 19 year veteran of the consumer healthcare unit, Howell will be taking on increased responsibilities as president of Miles' OTC business. Howell has held the position of VP marketing-U.S. for the division since last year. Since 1982, he has served as VP-sales and, before that, national sales manager. Howell replaces Roger Stoll, PhD, who moves to executive VP of Bayer's worldwide Diagnostics Business Group, located at Miles' Elkhart, Indiana headquarters. In taking the new position, Stoll leaves vacant his other title of chief administrative officer of Miles. Stoll joined Miles in 1986 from American Critical Care; he was president of the Baxter subsidiary before its sale to DuPont. The management moves at Miles were sparked by the appointment of Walter Wenninger, DVM, to general manager of Bayer AG's worldwide Self-Medication Business Group. Bayer's worldwide OTC division headquarters is located in Leverkusen, West Germany. Previously, Wenninger was executive VP of Miles Diagnostics and head of Bayer's worldwide diagnostics business. Wenninger joined Bayer in 1968 and held various positions in the company's pharmaceutical marketing and sales department. In 1978, he was selected as head of marketing and sales for ethical and self-medication products in Germany. Wenninger moved to the U.S. in 1984 as president of the Ames diagnostic division, which later merged with Miles Scientific to form Miles' Diagnostics Group. His promotion becomes effective on July 1, 1987.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

Latest Headlines
See All
UsernamePublicRestriction

Register

PS011875

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel